Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of SAB Biotherapeutics, Inc. - Warrant
Analyst Grade Summary
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
3
0
0
0
No Price
27.04.2026 19:58
Current Prices from SAB Biotherapeutics, Inc. - Warrant
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
SABSW
USD
27.04.2026 19:58
0,02 USD
-
Share Float & Liquidity
Free Float90,22 %
Shares Float8,62 M
Shares Outstanding9,56 M
Company Profile for SAB Biotherapeutics, Inc. - Warrant Share
SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology. It offers SAB-142 anti-thymocyte globulin for Type 1 diabetes; SAB-176 for seasonal influenza; and SAB-301 for Middle East Respiratory Syndrome Coronavirus (MERS-COV). SAB Biotherapeutics, Inc. was incorporated in 2014 and is based in Sioux Falls, South Dakota with an additional office in Cambridge, Massachusetts.
